These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 63434)

  • 1. [Coagulation-physiological manifestations and clinical side-effects of streptokinase therapy].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):468-71. PubMed ID: 63434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A; Vermylen J; Verstraete M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical parameters and thrombolytic success in recent arterial occlusions.
    Verstraete M
    Scand J Clin Lab Invest Suppl; 1967; 99():190-2. PubMed ID: 4228464
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characterization of various streptokinase dosage schedules through quantitative streptokinase, plasminogen and plasmin determinations in the plasma of patients].
    Büchner U; Martin M; Auel H
    Verh Dtsch Ges Inn Med; 1975; 81():1152-5. PubMed ID: 132799
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biologic data furnished by the experience of thrombolytic treatments with streptokinase].
    Samama M; Yver J; Casubolo L; Soria J; Bousser J
    Nouv Rev Fr Hematol; 1968; 8(1):84-92. PubMed ID: 4232155
    [No Abstract]   [Full Text] [Related]  

  • 6. The control of plasminogen and plasmin during thrombolytic therapy.
    Blix S
    Acta Med Scand; 1969 Nov; 186(5):479-82. PubMed ID: 4244879
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies of coagulative and fibrinolytic faculties between the Japanese monkey and the human.
    Suzuki K; Egawa H; Hashimoto S
    Thromb Haemost; 1977 Apr; 37(2):233-42. PubMed ID: 406688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory control of fibrinolytic therapy].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):30-7. PubMed ID: 2427412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory control of SK therapy.
    Conard J; Samama M
    Thromb Diath Haemorrh Suppl; 1973; 56():191-8. PubMed ID: 4805495
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of plasminogen with a coagulometric method].
    Jacobi E; Karges HE; Heimburger N
    Med Welt; 1975 Sep; 26(38):1696-9. PubMed ID: 1237775
    [No Abstract]   [Full Text] [Related]  

  • 11. The inhibition of plasmin by antithrombin III-heparin complex in vitro in human plasma and during streptokinase therapy in man.
    Telesforo P; Semeraro N; Verstraete M; Collen D
    Thromb Res; 1975 Oct; 7(4):669-76. PubMed ID: 128153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation studies during streptokinase, heparin and plasmin therapy].
    Perlick E; Conrad E; Zimmermann S; Müldner J; Bach H
    Z Gesamte Inn Med; 1968 Mar; 23(5):Suppl:80 c. PubMed ID: 4234981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Technics for the study of the blood coagulation and fibrinolytic system].
    Lasch HG; Heene D
    Internist (Berl); 1968 Feb; 9(2):42-8. PubMed ID: 4234941
    [No Abstract]   [Full Text] [Related]  

  • 14. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 15. The fibrinolytic enzyme system in the newborn.
    Beller F; Douglas GW; Epstein MD
    Am J Obstet Gynecol; 1966 Dec; 96(7):977-84. PubMed ID: 4224630
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and therapy of consumption coagulopathy].
    Lechner K
    Wien Klin Wochenschr; 1973 Jun; 85(26):467-70. PubMed ID: 4268703
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the effect of fibrinogen split products on the formation of platelet rich thrombi].
    Poliwoda H; Lill J; Wolf R; Christl HL
    Thromb Diath Haemorrh; 1968 Jul; 19(3):540-6. PubMed ID: 5708131
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombolytic treatment of chronic obturations of the pelvic arteries and the arteries of the lower extremities (author's transl)].
    Bruhn HD; Jipp P; Hagenah I
    Med Klin; 1973 Nov; 68(44):1430-6. PubMed ID: 4770985
    [No Abstract]   [Full Text] [Related]  

  • 19. [COMPARATIVE STUDIES ON THE EFFECT OF STREPTOKINASE AND STREPTOKINASE-ACTIVATED PLASMINOGEN IN THROMBOLYTIC THERAPY].
    DEUTSCH E; STACHER A
    Wien Klin Wochenschr; 1963 Sep; 75():667-70. PubMed ID: 14059190
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.